Double homeobox protein A (DUXA)

Double homeobox protein A (DUXA) is a member of the homeobox gene family, specifically classified among PRD-like homeobox genes. Homeobox genes encode proteins containing a conserved 60–63 amino acid DNA-binding domain (the homeodomain), and DUXA contains two such homeodomains[1][2][3]. DUXA functions as a transcription factor and has been detected primarily in early embryonic development—its mRNA is expressed in human 8-cell stage embryos and at lower levels in a subset of human embryonic stem cells[2]. DUXA is thought to act mainly as a transcriptional repressor[3]. Experimental data indicate no (or extremely low) evidence of DUXA mRNA expression in most somatic tissues, and several related processed pseudogenes exist, possibly reflecting ancestral germline or embryonic expression[1][3]. While DUXA is structurally related to other double homeobox proteins (e.g., DUXB), and paralogous to ARX, direct functional and disease association data are limited. Some gene-disease databases note links to rare entities (e.g., Facioscapulohumeral muscular dystrophy 1), but DUXA is not widely considered a therapeutic target, and there are no approved drugs or recognized mechanisms of action targeting it[3]. It is not associated with established biomarkers or specific safety concerns. Additional context: - DUXA is part of a broader family of homeobox genes important in developmental regulation but, unlike several other family members, appears to play a restricted and as-yet not fully defined role in humans[2][4]. - The gene is well classified at the molecular (transcription factor) and structural (homeobox protein) levels but lacks evidence for direct targeting or therapeutic intervention in current biomedical paradigms[1][3].

Other names

Double homeobox ADUXAdouble homeobox protein A